Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
- Written by PR Newswire Asia - Asian Spectator
![]() |
MELBOURNE, Australia and INDIANAPOLIS, July 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational performance for the quarter ended June 30, 2026 (Q2 2026).
Q2 2026 Highlights[1]
- Group revenue of US$247 million, up 7% quarter-over-quarter (QoQ) and up...





